Ligand validation:4LV9

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4LV9_EDO_B_605	81%	84%	0.104	0.955	0.41	0.35	-	-	0	0	100%	1
4LV9_EDO_A_605	74%	85%	0.103	0.932	0.47	0.27	-	-	0	0	100%	1
4LTS_EDO_A_604	94%	85%	0.069	0.968	0.48	0.27	-	-	0	0	100%	1
4LWW_EDO_B_610	93%	80%	0.072	0.966	0.4	0.45	-	-	0	0	100%	1
4N9E_EDO_A_608	93%	83%	0.069	0.962	0.49	0.29	-	-	0	0	100%	1
4O1A_EDO_A_603	89%	81%	0.1	0.98	0.45	0.38	-	-	0	0	100%	1
4O16_EDO_A_603	76%	89%	0.125	0.962	0.51	0.15	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.